Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biological response modifiers and differentiation inducers. Current status in cancer research.

× No keyword cloud information.

26 in total

1. Lithium reinduction of acute myeloblastic leukemia.

Authors: L E Orr; J F McKernan
Journal: Lancet Date: 1979-02-24 Impact factor: 79.321

2. Lithium therapy of aplastic anemia.

Authors: S F Blum
Journal: N Engl J Med Date: 1979-03-22 Impact factor: 91.245

3. Interferon treatment for multiple myeloma.

Authors: R Alexanian; J Gutterman; H Levy
Journal: Clin Haematol Date: 1982-02

4. Lithium in acute myeloid leukaemia.

Authors: D Charron; A J Barrett; A Faille; N Alby; T Schmitt; L Degos
Journal: Lancet Date: 1977-06-18 Impact factor: 79.321

5. Lithium-induced granulocytosis.

Authors: G Tisman; S J Wu
Journal: Lancet Date: 1977-07-30 Impact factor: 79.321

6. Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2.

Authors: B S Wang; E H Heacock; C X Zheng; N L Tilney; J A Mannick
Journal: Transplantation Date: 1982-04 Impact factor: 4.939

7. Lithium stimulation of granulopoiesis.

Authors: A H Rossof; K M Fehir
Journal: N Engl J Med Date: 1978-02-02 Impact factor: 91.245

8. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

Authors: J U Gutterman; S Fine; J Quesada; S J Horning; J F Levine; R Alexanian; L Bernhardt; M Kramer; H Spiegel; W Colburn; P Trown; T Merigan; Z Dziewanowski
Journal: Ann Intern Med Date: 1982-05 Impact factor: 25.391

9. Human leukocyte interferon-mediated granulopoietic differentiation arrest and its abrogation by lithium carbonate.

Authors: D S Verma; G Spitzer; J U Gutterman; M Beran; A R Zander; K B McCredie
Journal: Am J Hematol Date: 1982-02 Impact factor: 10.047

10. Studies of thymopoietin pentapeptide (TP5) on experimental tumors. I. TP5 relieves immunosuppression in tumor-bearing mice.

Authors: C Y Lau; E Y Wang; G Goldstein
Journal: Cell Immunol Date: 1982-01-15 Impact factor: 4.868